Verimedix runs sleep medicine billing services for sleep labs, HSAT programs and physician sleep practices - in-lab polysomnography and home sleep test claims, TC/26 split billing, prior authorization against HSAT-first payer policies, PAP adherence documentation, and appeals on the medical-necessity denials that stall sleep revenue.

Sleep medicine billing services are outsourced revenue cycle management for sleep testing and therapy - in-lab polysomnography (CPT 95810, 95811), unattended home sleep apnea tests (CPT 95800, 95801, 95806 commercially and HCPCS G0398-G0400 for Medicare), PAP initiation and management, and the DME pathway for CPAP and BiPAP devices. The work covers prior authorization against HSAT-first payer policies, NCD 240.4 and LCD medical-necessity documentation, TC/26 component splitting, adherence-data tracking, claim submission, denial appeals and A/R follow-up. Pricing typically runs 4-8% of net collections, or roughly $5-$10 per claim.
Sleep medicine practices face a uniquely layered billing environment. Diagnostic services range from attended in-lab polysomnography (CPT 95810, 95811) to unattended home sleep apnea tests (HSAT; CPT 95800, 95801, 95806), each with distinct technical and professional component rules, documentation requirements, and coverage criteria. Medicare and most commercial payers require a face-to-face evaluation, documented symptoms (snoring, witnessed apneas, excessive daytime sleepiness), and prior authorization before authorizing overnight studies—gaps in pre-authorization workflow are a leading cause of denied claims.
A significant revenue stream for sleep medicine lies in PAP therapy management, including follow-up visits (99213–99215), re-scoring of diagnostic data, and the downstream DME billing pathway for CPAP/APAP/BiPAP devices and supplies. Many sleep practices either provide DME directly or coordinate billing with a separate DME supplier; in either case, the practice's professional services must be clearly separated from equipment billing to avoid bundling errors. HCPCS codes E0601 (CPAP), E0470 (BiPAP without backup rate), and E0471 (BiPAP with backup rate) are subject to Medicare's competitive bidding program and strict compliance documentation (AHI thresholds, 90-day adherence data).
Payer policies for sleep studies vary substantially: Medicare National Coverage Determination 240.4 governs OSA diagnostic and treatment coverage, while commercial payers often impose their own medical necessity criteria and preferred testing modalities. Split-night studies (95811) require documentation that diagnostic criteria were met in the first portion before initiating titration. Proper use of place-of-service (POS) codes—POS 11 for office, POS 19/22 for outpatient hospital sleep lab—and understanding of the technical vs. professional component split are essential for accurate reimbursement and compliance.
Two 2026 changes matter for revenue planning. First, CMS applied a -2.5% efficiency adjustment to the work RVUs of non-time-based diagnostic services in the CY 2026 Physician Fee Schedule, which includes polysomnography codes 95810 and 95811 - per-study payment is modestly lower than 2025, so capture and denial prevention have to make up the difference. Second, the current unattended home sleep test codes 95800, 95801 and 95806 are deleted effective January 1, 2027 and replaced by a six-code family structured around device complexity and the number of parameters recorded. They remain billable through 2026, which makes this year a documentation transition: sleep records should already be capturing device type, parameter count and monitoring specificity so the crosswalk in January 2027 is a mapping exercise rather than a rewrite. Medicare continues to require G0398-G0400 rather than the CPT codes for home testing, and NCD 240.4 still governs OSA coverage.
Outsourced billing is published at 4-10% of net collections across specialties. Sleep practices are usually quoted in the lower-middle of that band, and Verimedix engagements typically land at 4-8%, or roughly $5-$10 per claim for practices that prefer a per-claim model. Where a program lands inside the range is driven less by claim count than by mix: a lab running attended studies with a TC/26 split and heavy prior-authorization traffic is more work per claim than a physician practice reading home studies.
The number worth comparing it to is not a competitor's percentage but the cost of a denial. A prior authorization that expired before the study, an in-lab PSG ordered where the payer required a home test first, or PAP adherence data that never made it into the file - each one turns a completed study into unpaid work, and re-authorizing after the fact usually is not possible. Prior authorization already adds roughly two to four weeks between the physician order and equipment delivery, and denial rates on first submission in Medicare's PAP prior-authorization pilot states ran 15-25%. A billing partner that clears authorization before the patient sleeps is worth more than a point of fee difference.
| Fee model | Typical range | Best fit |
|---|---|---|
| Percentage of net collections | 4-8% of net collections | Most sleep labs and physician sleep practices; the vendor is paid only when the practice is |
| Per claim | About $5-$10 per claim | High-volume HSAT programs with predictable, repeatable claim types |
| Coding and interpretation only | Priced per study | Labs that keep A/R in-house but need sleep-fluent coders for TC/26 and split-night rules |
| Prior authorization support | Add-on, per authorization | Practices whose denials cluster on authorization rather than coding |
These are engagement ranges, not a rate card. Payer mix, the share of in-lab versus home studies, whether you bill the DME pathway, and the size of an existing A/R backlog all move the quote - we price after looking at your study volume and aging.
Below are commonly billed codes our certified coders manage for sleep medicine practices. Always confirm payer-specific coverage and current code values.
| Code | Description | Billing note |
|---|---|---|
95810 | Polysomnography, attended; age 6 or older, with 4+ additional parameters of sleep, CPAP titration not included | In-lab diagnostic sleep study; requires sleep technologist attendance; bill with TC/26 modifiers when split between facility and physician |
95811 | Polysomnography, attended; age 6 or older, with 4+ additional parameters, with initiation of CPAP or BPAP therapy | Split-night or full-night titration study; document that AHI criteria were met in first portion for split-night |
95800 | Sleep study, unattended, simultaneous recording of heart rate, oxygen saturation, respiratory airflow, and respiratory effort | Type III HSAT; most commonly covered home sleep test; requires physician order and documented clinical criteria |
95806 | Sleep study, unattended, simultaneous recording of heart rate, oxygen saturation, respiratory airflow, respiratory effort, and limb muscle activity | Type II/III expanded HSAT with limb movement; confirm payer coverage—some limit to Type III only |
95801 | Sleep study, unattended, minimum recording of heart rate, oxygen saturation, and respiratory airflow or peripheral arterial tone | Type IV limited HSAT; narrower coverage—verify payer policy before ordering |
99213 | Office or other outpatient visit, established patient, moderate complexity (E/M) | Common follow-up for PAP therapy compliance review; document 30-day and 90-day adherence data |
94660 | CPAP initiation and management, including face-to-face patient education and device set-up | Professional service for CPAP initiation; not separately billable on same DOS as E/M unless -25 modifier documented |
E0601 | CPAP device, non-self-adjusting (HCPCS DME) | DME billing; subject to Medicare competitive bidding; requires AHI ≥5 with symptoms or AHI ≥15 from diagnostic study |
G0398 | Home sleep study with type II portable monitor (Medicare-specific HCPCS) | Legacy Medicare code; verify current applicability—crosswalk to CPT 95800 family per payer |
Our standard operating procedures for sleep medicine revenue cycle management — the step-by-step workflow we follow on every claim:
These are the issues we see most often in sleep medicine billing — and exactly how we resolve them:
Many payers now require HSAT as a first step before authorizing attended PSG. Denial fix: document clinical contraindications to HSAT (moderate-to-severe COPD, CHF, neuromuscular disease, hypoventilation suspected) in the ordering note; attach to auth request to justify direct in-lab study.
When the sleep lab is hospital-owned but the reading physician is an independent contractor, both TC and 26 must be billed correctly by the respective entity. Submitting the global code (without modifier) by either party causes overpayment or claim conflict. Fix: confirm ownership structure and apply -TC or -26 accordingly on every claim.
Medicare and commercial payers require a signed, dated physician interpretation report that includes AHI/RDI, oxygen nadir, and clinical impression. Claims lacking a compliant report are denied for insufficient documentation. Fix: implement a report template checklist tied to the billing workflow that triggers claim hold until report is finalized.
CPAP/APAP claims denied when the ordering physician's chart does not reflect the required face-to-face evaluation within 6 months before the HSAT order, or when 90-day adherence data is not properly documented. Fix: build a compliance calendar in your PM system to track initial order dates, 31-day follow-up visits, and adherence download dates.
Using POS 11 (office) for studies performed in a hospital-based sleep lab (POS 22) reduces payment and creates compliance risk. Fix: map each sleep lab location to its correct POS code and tie POS to the rendering facility in your PM system rather than defaulting to the practice address.
Verimedix works inside the systems sleep medicine practices already use, including:
Outsourced sleep billing is generally quoted at 4-10% of net collections, and Verimedix engagements typically land at 4-8% depending on study mix, payer mix and prior-authorization volume. High-volume home-test programs can take a per-claim fee of roughly $5-$10 instead, and coding-only engagements are priced per study. There is no setup fee and no long-term contract.
CMS applied a -2.5% efficiency adjustment to work RVUs for non-time-based diagnostic codes in the CY 2026 Physician Fee Schedule, which includes 95810 and 95811, so per-study payment is slightly below 2025. Separately, the unattended home sleep test codes 95800, 95801 and 95806 are deleted effective January 1, 2027 in favour of a six-code complexity-based family - they are still billable through 2026, so this year is the documentation transition window.
95810 is a diagnostic polysomnography without PAP titration; 95811 includes initiation of CPAP or BiPAP therapy. For a split-night protocol, 95811 is used when titration occurs during the second half of the same night after diagnostic criteria are met in the first half.
Yes, if a separate and distinct evaluation/management service is performed and documented on the same day. Apply modifier -25 to the E/M code to indicate a separately identifiable service beyond the study interpretation.
Traditional Medicare does not require prior authorization for HSAT CPT codes, but requires documented clinical criteria per NCD 240.4 (AHI symptoms, physician order). Many Medicare Advantage plans do require prior auth—always verify at the plan level.
Sleep studies are not laterality-based services. The 95810/95811 series captures the full study as a single unit. Bilateral modifiers (RT/LT) do not apply to polysomnography.
G47.33 (obstructive sleep apnea, adult) is the most common. Also used: G47.30 (sleep apnea, unspecified), G47.31 (primary central sleep apnea), G47.37 (central sleep apnea in conditions classified elsewhere), and R06.83 (snoring) for screening contexts.
Coverage varies. Most major commercial payers (Aetna, Cigna, UnitedHealthcare, BCBS) cover Type III HSAT (CPT 95800) as a first-line test for uncomplicated OSA. Some limit coverage to specific diagnostic devices or require HSAT-first policies. Always verify medical necessity criteria in the applicable payer clinical policy bulletin before ordering.
If the practice owns the HSAT devices and a physician interprets the results, the practice may bill the global code (no modifier) or split into -TC for the device/recording and -26 for interpretation. If billed globally, revenue is captured in a single claim; verify that the practice's payer contracts support global sleep study billing.
Verimedix handles the entire sleep medicine revenue cycle — coding, submission, denials, and A/R — so your team can focus on patients.